Genetic Testing for Developmental Disabilities Low Among Children Enrolled in Medicaid
By Lori Solomon HealthDay Reporter
FRIDAY, June 27, 2025 -- Clinical implementation of genetic testing in children with neurodevelopmental disabilities in the Medicaid-enrolled population remains low, according to a study published online June 18 in Genetics in Medicine.
Tashalee R. Brown, M.D., Ph.D., from the University of California, Los Angeles, and colleagues examined clinical implementation of existing genetic testing medical guidelines for children with autism spectrum disorder (ASD) and/or intellectual disability (ID) among enrollees of Medicaid or Children’s Health Insurance Program plans. Analysis included data from 241,060 children aged 7 to 17 years.
The researchers found that the frequency of genetic testing was low across diagnoses, with ASD + ID showing the highest frequency of 25.94 percent. Children with ASD + ID had the highest odds of genetic testing (adjusted odds ratio, 29.43) versus a random sample of children without ASD or ID. In 2013, cytogenetics and Fragile X testing were the predominant testing types used, followed by increasing use of chromosomal microarray analysis and gene panels in 2014 to 2016.
"Genetic testing can offer valuable insights for diagnosis and care planning," Brown said in a statement. "But our findings show a major gap between what’s recommended and what’s actually happening in clinical practice among children who receive health insurance through Medicaid."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Opportunistic Community Screening IDs Uncontrolled Cardiovascular Risk Factors
FRIDAY, Aug. 15, 2025 -- Opportunistic pop-up community screening identifies a high prevalence of uncontrolled cardiovascular risk factors, according to a study published online...
Missed Opportunity Common in Patients With High-Grade Serous Ovarian Cancer
FRIDAY, Aug. 15, 2025 -- A considerable proportion of patients with high-grade serous cancer (HGSC) have missed opportunities for risk assessment with genetic testing and for...
EHR Notes Reveal Potential Racial Bias in Doctors' Perception of Patient Credibility
FRIDAY, Aug. 15, 2025 -- An analysis of more than 13 million electronic health record (EHR) notes shows potential racial bias in how doctors document patient trustworthiness...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.